New research published by the U.S. National Institute of Health, and published in-print by the journal Behavioural Brain Research, has found
that cannabidiol can attenuate catalepsy induced by haloperidol, and can prevent it if taken prior to the use of haloperidol.
Catalepsy is a trancelike state marked by loss of voluntary motion, sensations and consciousness accompanied by rigidity of the body, and haloperidol is an antipsychotic used to treat certain medical conditions such as Tourette syndrome and bipolar disorder.
“Given that CBD reduces psychotic symptoms without inducing extrapyramidal motor side-effects in animal models and schizophrenia patients, it has been proposed to act as an atypical antipsychotic”, states the study’s abstract. “In addition, CBD reduced catalepsy induced by drugs with distinct pharmacological mechanisms, including the typical antipsychotic haloperidol”
Read moreNew Study: CBD Prevents and Reverses Antipsychotic-Induced Catalepsy